id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FTC-2012-0091-0001,FTC,FTC-2012-0091,"Proposed Consent Agreements: Watson Pharmaceuticals, Inc.; Actavis Inc.; Actavis Pharma Holding 4 ehf.; and Actavis S.a.r.l.",Notice,,2012-10-22T04:00:00Z,2012,10,2012-10-22T04:00:00Z,2012-11-15T04:59:59Z,2012-11-02T18:32:16Z,2012-25957,0,0,090000648114a70b